LONG-TERM EFFICACY AND SAFETY OF SUBCUTANEOUS C1-INHIBITOR IN ELDERLY PATIENTS WITH HEREDITARY ANGIOEDEMA TYPE I/II

MLA

Bernstein, J., et al. “Long-Term Efficacy and Safety of Subcutaneous C1-Inhibitor in Elderly Patients with Hereditary Angioedema Type I/Ii.” Annals of Allergy, Asthma & Immunology, vol. 121, no. 5, Number 5 Supplement 1, Nov. 2018, p. S32. EBSCOhost, https://doi.org/10.1016/j.anai.2018.09.100.

APA

Bernstein, J., Schwartz, L., Feuersenger, H., Pragst, I., Chiao, J., & Jacobs, I. (2018). Long-Term Efficacy and Safety of Subcutaneous C1-Inhibitor in Elderly Patients with Hereditary Angioedema Type I/Ii. Annals of Allergy, Asthma & Immunology, 121(5, Number 5 Supplement 1), S32. https://doi.org/10.1016/j.anai.2018.09.100

Chicago

Bernstein, J., L. Schwartz, H. Feuersenger, I. Pragst, J. Chiao, and I. Jacobs. 2018. “Long-Term Efficacy and Safety of Subcutaneous C1-Inhibitor in Elderly Patients with Hereditary Angioedema Type I/Ii.” Annals of Allergy, Asthma & Immunology 121 (5, Number 5 Supplement 1): S32. doi:10.1016/j.anai.2018.09.100.